how is bitcoin valued Overview

South Korea's Public Affairs Office: The arrest of President Yin Xiyue will be discussed. On the 11th, South Korea's Senior Public Officials' Crime Investigation Office (referred to as the Public Affairs Office) said that it is working hard to launch an investigation and will discuss the arrest of President Yin Xiyue, "with full will". Wu Dongyun, head of the Public Mediation Office, made the above statement when attending the meeting of the Legal and Judicial Committee of the National Assembly on the same day. Wu Dongyun said that if circumstances permit, an attempt will be made to arrest Yin Xiyue by emergency arrest or applying for issuing an arrest warrant. Earlier in the day, the special investigation team of the National Investigation Headquarters under the South Korean Police Agency said that the Presidential Palace, the South Korean Police Agency, the Seoul Police Agency and the National Guard had been seized and searched. (Xinhua News Agency)Hong kong stocks minimally invasive robots rose more than 13%. The company completed the placement of a total of 34.7 million shares, and the net proceeds from the placement were about HK$ 266 million.The Shanghai Municipal Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Reagents in Shanghai (2025-2027), which was formulated by the Shanghai Municipal Science and Technology Commission to promote the innovative development of the scientific instruments and reagents industry in Shanghai. Adhere to the working idea of "following the development law, facing the needs of the industry, strengthening superior products, cultivating and expanding enterprises, and creating a development ecology", adhere to the product as the traction, strengthen key core technology research, vigorously cultivate first-class enterprises, and promote the high-quality development of the industry. By 2027, 1-2 technical test and verification platforms will be built, and more than 5 application scenarios and user experience centers will be built. The scientific and technological innovation ability of scientific instruments and scientific research reagents in our city will be further enhanced, and the industrial innovation ecology will be further improved. More than 5 leading scientific and technological enterprises in subdivided tracks will be cultivated, and more than 5 scientific instruments and 10 scientific research reagents reaching the international leading level will be formed. The industrial output value of scientific instruments and scientific research reagents will be about 45 billion yuan.

AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit.Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%.Xinshida Inverter has successfully obtained the type approval certificate of China Classification Society. Recently, Xinshida Inverter AS710M has successfully obtained the type approval certificate issued by China Classification Society (CCS), which indicates that Xinshida Electric's products meet the strict standards of the international shipping industry, and also indicates that the company will further expand its market share in the field of ship and ocean engineering.

According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).Volvo Cars: The Daqing plant has rolled off 500,000 vehicles.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.